$IPHA
Innate Pharma SA
CIK:0001598599|SEC Filings
Consolidated Statements of Financial Position - EUR (€) |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Non-current assets | |||
| Intangible assets | € 0 | € 0 | € 416,000 |
| Property and equipment | 4,356,000 | 5,133,000 | 6,322,000 |
| Non-current financial assets | 10,455,000 | 10,281,000 | 9,796,000 |
| Other non-current assets | 947,000 | 575,000 | 87,000 |
| Trade receivables and others - non-current | 251,000 | 9,328,000 | 10,554,000 |
| Total non-current assets | 16,009,000 | 25,317,000 | 27,175,000 |
| Current assets | |||
| Cash and cash equivalents | 28,092,000 | 66,396,000 | 70,605,000 |
| Short-term investments | 6,218,000 | 14,374,000 | 21,851,000 |
| Trade receivables and others - current | 12,400,000 | 4,972,000 | 55,557,000 |
| Total current assets | 46,710,000 | 85,742,000 | 148,013,000 |
| TOTAL ASSETS | 62,719,000 | 111,059,000 | 175,187,000 |
| Shareholders' equity | |||
| Share capital | 4,686,661 | 4,192,000 | 4,044,000 |
| Share premium | 408,033,000 | 390,979,000 | 384,255,000 |
| Retained earnings | (386,365,000) | (336,893,000) | (329,323,000) |
| Other reserves | 1,118,000 | 27,000 | 495,000 |
| Net income (loss) | (49,177,000) | (49,471,000) | (7,570,000) |
| Total shareholders’ equity | (21,704,000) | 8,834,000 | 51,901,000 |
| Non-current liabilities | |||
| Collaboration liabilities – non-current portion | 31,748,000 | 41,128,000 | 45,030,000 |
| Financial liabilities – non-current portion | 13,771,000 | 22,286,000 | 30,957,000 |
| Defined benefit obligations | 1,923,000 | 2,730,000 | 2,441,000 |
| Deferred revenue – non-current portion | 0 | 2,825,000 | 4,618,000 |
| Provisions – non-current portion | 332,000 | 274,000 | 603,000 |
| Total non-current liabilities | 47,774,000 | 69,243,000 | 83,650,000 |
| Current liabilities | |||
| Trade payables and others | 15,042,000 | 16,007,000 | 17,018,000 |
| Collaboration liabilities – current portion | 6,501,000 | 7,443,000 | 7,647,000 |
| Financial liabilities – current portion | 8,802,000 | 8,709,000 | 8,936,000 |
| Deferred revenue – current portion | 2,825,000 | 616,000 | 5,865,000 |
| Provisions – current portion | 3,479,000 | 207,000 | 171,000 |
| Total current liabilities | 36,649,000 | 32,982,000 | 39,636,000 |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | € 62,719,000 | € 111,059,000 | € 175,187,000 |